In the next step, we processed blood samples from 36 cancer patients and 12 healthy donors (cohort 1) using protocol A and measured the gene expression levels of EpCAM, MAL2, PPIC, and TUSC3 in the enriched cell fractions. The gene discussed is MAL2; the disease is cancer.